The GLP is committed to full transparency. Download and review our 2019 Annual Report

Gene-editing ‘vaccine’ could radically change heart disease risk

| | February 6, 2020
heart articlelarge
Image: New York Times
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

As many as 50 percent of heart attacks strike without any warning signs and in individuals with no history of heart disease. When it comes to fatal heart attacks, the victim’s genes often drive this tragic turn of events. But imagine a world where years before someone’s heart malfunctions, a single infusion reduced their risk of a heart attack by up to 90 percent. That’s the moonshot Dr. Kiran Musunuru is aiming for: the world’s first heart attack “vaccine.”

It’s not a vaccine in the traditional sense — it doesn’t activate the immune system. But, like a vaccine, the concept hinges on a single dose therapy that could confer “enduring and possibly lifelong protection against heart disease,” Musunuru says.

Related article:  3 modern adaptations that prove humans are still evolving

In the future, people could still get heart attacks from unhealthy diets, lack of exercise, and environmental factors like pollution. But through this “vaccine” the potentially harmful genes linked to heart attacks would be effectively neutralized before they could cause any harm.

Currently, this process only works in mice. But if the technique is successfully used to edit the human genome, it could radically change the lifespan and quality of life for millions of people around the world at risk of heart disease.

Read the original post

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend